SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Lack of Potassium Linked to High Blood Pressure, University of Texas MD Anderson Cancer Center Study
November 10, 2008
 · 
1 min read
Lone Star Bio
Genetic Predictors Of Esophageal Cancer Identified, University of Texas MD Anderson Cancer Center Study
November 5, 2008
 · 
1 min read
Lone Star Bio
Baylor College of Medicine Scientists Turbo-Charge Immune Cells To Fight Cancer
November 3, 2008
 · 
1 min read
Lone Star Bio
Vitamin E May Slash Lung Cancer Risk, University of Texas MD Anderson Cancer Center Study
November 3, 2008
 · 
1 min read
Drug Development
Rare Cancer Requires Support From Immune System To Develop, University of Texas Southwestern Medical Center Study
October 31, 2008
 · 
1 min read
BioCapital
National Institutes of Health (NIH) Release: University of Texas Southwestern Medical Center And Indiana University School of Medicine Researchers Identify Mechanism And Possible Drug Treatment For Growth Of Nerve Tumors In Neurofibromatosis
October 31, 2008
 · 
5 min read
Lone Star Bio
Insulin, Light Treatment Therapies May Not Help Preemies, University of Cambridge Study And University of Texas Medical School Study
October 30, 2008
 · 
1 min read
Lone Star Bio
Exploring Use Of Fat Cells As Heart Attack Therapy, University of Houston Study
October 29, 2008
 · 
1 min read
Drug Development
New Optimer Pharmaceuticals, Inc. Drug Treats Traveler’s Diarrhea, University of Texas Study
October 29, 2008
 · 
1 min read
Biotech Bay
BioPharm Executive: No Free Lunch
October 29, 2008
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Load More